These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 10839330)

  • 41. [Schizophrenia and informed consent to research].
    Fovet T; Amad A; Thomas P; Jardri R
    Encephale; 2015 Oct; 41(5):394-402. PubMed ID: 25127894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decisional capacity for research participation in individuals with mild cognitive impairment.
    Jefferson AL; Lambe S; Moser DJ; Byerly LK; Ozonoff A; Karlawish JH
    J Am Geriatr Soc; 2008 Jul; 56(7):1236-43. PubMed ID: 18482298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Getting meaningful informed consent from older adults: a structured literature review of empirical research.
    Sugarman J; McCrory DC; Hubal RC
    J Am Geriatr Soc; 1998 Apr; 46(4):517-24. PubMed ID: 9560079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cognitive insight as an indicator of competence to consent to treatment in schizophrenia.
    Raffard S; Fond G; Brittner M; Bortolon C; Macgregor A; Boulenger JP; Gely-Nargeot MC; Capdevielle D
    Schizophr Res; 2013 Mar; 144(1-3):118-21. PubMed ID: 23313358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Informed consent in chronic schizophrenia?
    Jones GH
    Br J Psychiatry; 1995 Nov; 167(5):565-8. PubMed ID: 8564309
    [No Abstract]   [Full Text] [Related]  

  • 46. Long-term, assenting psychiatric patients: decisional capacity and the quality of care.
    Hoge SK; Feucht-Haviar TC
    Bull Am Acad Psychiatry Law; 1995; 23(3):343-52. PubMed ID: 8845525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determining when impairment constitutes incapacity for informed consent in schizophrenia research.
    Kim SY; Appelbaum PS; Swan J; Stroup TS; McEvoy JP; Goff DC; Jeste DV; Lamberti JS; Leibovici A; Caine ED
    Br J Psychiatry; 2007 Jul; 191():38-43. PubMed ID: 17602123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decisional capacity of depressed elderly to consent to electroconvulsive therapy.
    Lapid MI; Rummans TA; Pankratz VS; Appelbaum PS
    J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):42-6. PubMed ID: 15018698
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determinants of Capacity to Consent to Research on Alzheimer's disease.
    Palmer BW; Harmell AL; Pinto LL; Dunn LB; Kim SY; Golshan S; Jeste DV
    Clin Gerontol; 2017; 40(1):24-34. PubMed ID: 28154452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coercion and informed consent in research involving prisoners.
    Moser DJ; Arndt S; Kanz JE; Benjamin ML; Bayless JD; Reese RL; Paulsen JS; Flaum MA
    Compr Psychiatry; 2004; 45(1):1-9. PubMed ID: 14671730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Informed consent and ethical reporting of research in clinical trials involving participants with psychotic disorders.
    Weissinger GM; Ulrich CM
    Contemp Clin Trials; 2019 Sep; 84():105795. PubMed ID: 31247285
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Importance of decisional capacity tools in obtaining informed consent in clinical settings.
    Radenković M
    Bioethics; 2023 Feb; 37(2):146-153. PubMed ID: 36426407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimistic bias in the perception of personal risk: patterns in schizophrenia.
    Prentice KJ; Gold JM; Carpenter WT
    Am J Psychiatry; 2005 Mar; 162(3):507-12. PubMed ID: 15741467
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychometric Properties of a Decisional Capacity Screening Tool for Individuals Contemplating Participation in Alzheimer's Disease Research.
    Seaman JB; Terhorst L; Gentry A; Hunsaker A; Parker LS; Lingler JH
    J Alzheimers Dis; 2015; 46(1):1-9. PubMed ID: 25765917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Agreement between instruments for rating treatment decisional capacity.
    Gurrera RJ; Karel MJ; Azar AR; Moye J
    Am J Geriatr Psychiatry; 2007 Feb; 15(2):168-73. PubMed ID: 17272738
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors of providing informed consent or assent for research participation in assisted living residents.
    Black BS; Brandt J; Rabins PV; Samus QM; Steele CD; Lyketsos CG; Rosenblatt A
    Am J Geriatr Psychiatry; 2008 Jan; 16(1):83-91. PubMed ID: 18165463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the capacity of inpatients with chronic schizophrenia to provide informed consent for participation in clinical trials; use of the Hebrew version of the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR).
    Linder M; Lev-Ari L; Kurs R; Melamed Y
    Isr Med Assoc J; 2012 Aug; 14(8):470-4. PubMed ID: 22977964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Competence to Consent and Its Relationship With Cognitive Function in Patients With Schizophrenia.
    Sugawara N; Yasui-Furukori N; Sumiyoshi T
    Front Psychiatry; 2019; 10():195. PubMed ID: 31031653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancing the informed consent process in psychiatric outpatients with a brief computer-based method.
    Morán-Sánchez I; Luna A; Pérez-Cárceles MD
    Psychiatry Res; 2016 Nov; 245():354-360. PubMed ID: 27591409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical correlates of the ability to consent to research participation in brain metastasis.
    Gerstenecker A; Gammon M; Marotta D; Fiveash J; Nabors B; Mulhauser K; Triebel K
    Psychooncology; 2020 Oct; 29(10):1655-1661. PubMed ID: 33463869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.